Denintuzumab MMAF Antibody
Denintuzumab-MMAF is a CD19-targeting antibody-drug conjugate (ADC) incorporating the cytotoxic agent monomethyl auristatin F (MMAF) . It is a research tool for investigating novel therapies against B-cell malignancies, including acute lymphoblastic leukemia (ALL), in both in vitro and in vivo experimental models.
Product Specifications
Target
Immunology/Inflammation related
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Molecular Weight
144.54 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LY427938 100 µg
FAM25BP (NM_001137556) Human Over-expression Lysate
Sign In for Pricing
View Details 